ASN
KYTX icon

Advisory Services Network’s Kyverna Therapeutics KYTX Stock Holding History

Advisory Services Network’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$742 Buy
+86
New +$717 ﹤0.01% 4362
2025
Q4 		– Sell
-86
Closed -$516 – 4325
2025
Q3 		$516 Buy
+86
New +$344 ﹤0.01% 4051

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Advisory Services Network's KYTX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Kyverna Therapeutics (KYTX) in Q1 2026: 86 shares worth $742. The stake represents ﹤0.01% of the portfolio and ranks #4362 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in KYTX as recently as Q3 2025.

Advisory Services Network first reported a position in KYTX in Q3 2025 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Advisory Services Network held 86 shares of Kyverna Therapeutics worth $742 as of Q1 2026.
  • Kyverna Therapeutics was a new Advisory Services Network position in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4362 holding.
  • Advisory Services Network first reported a position in Kyverna Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.